• Capricor Therapeutics Issues Progress Report on Its Cardiac Cell Therapy CAP-1002 for DMD
  • Heart Association Awards Grant to University Scientist for Development of New Duchenne Therapies
  • Researchers Develop Newborn Screening Tool for Duchenne
  • Mitobridge’s Investigational DMD Therapy MA-0211 to Be Tested in Healthy Volunteers in Initial Clinical Trial
  • Phase 2 Trial of Muscle Therapy ACE-083 for Charcot-Marie-Tooth Disease Doses 1st Patient
  • My Walk with Faith While Living with MD
  • Casey’s General Stores Partners with MDA to Send Kids with Muscular Dystrophy to Summer Camp
  • Jiffy Lube, MDA Launch 6th Annual MUSCLE UP! Campaign
  • New Gene Therapy to Fix Dystrophin Deficiency in DMD Shows Promise in Mice, Study Shows
  • FDA Paves Way for Capricor to Hold Phase 2 Trial of CAP-1002 for Duchenne MD
  • Microdystrophin Gene Therapy Shows Promise in Dogs with Duchenne Muscular Dystrophy, Study Shows
  • Emflaza’s Benefits for Duchenne Patients and Price Structure Addressed in Interview with PTC